PACIRA BIOSCIENCES INC (PCRX) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:PCRX • US6951271005

20.54 USD
+0.45 (+2.24%)
At close: Jan 30, 2026
20.54 USD
0 (0%)
After Hours: 1/30/2026, 8:12:30 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PCRX revenue by date.PCRX revenue by date.
666.8M
23.14%
674.978M
1.23%
700.966M
3.85%
744.49M
6.21%
806.02M
8.26%
881.47M
9.36%
925.99M
5.05%
972.14M
4.98%
980M
0.81%
978M
-0.20%
948.7M
-3.00%
729.3M
-23.13%
EBITDA
YoY % growth
PCRX ebitda by date.PCRX ebitda by date.
162.4M
0.68%
166.321M
2.41%
180.816M
8.72%
208.07M
15.07%
223.44M
7.39%
246.84M
10.47%
274.99M
11.40%
286.11M
4.04%
261.94M
-8.45%
N/AN/AN/A
EBIT
YoY % growth
PCRX ebit by date.PCRX ebit by date.
70.9M
-46.61%
90.747M
27.99%
102.031M
12.43%
181.55M
77.94%
189.66M
4.47%
209.2M
10.30%
250.99M
19.98%
268.21M
6.86%
288.26M
7.48%
390.9M
35.61%
242.12M
-38.06%
N/A
Operating Margin
PCRX operating margin by date.PCRX operating margin by date.
10.63%13.44%14.56%24.39%23.53%23.73%27.11%27.59%29.41%39.97%25.52%N/A
EPS
YoY % growth
PCRX eps by date.PCRX eps by date.
2.59
-13.38%
2.92
12.74%
3.21
9.93%
3.01
-6.13%
3.48
15.34%
3.92
12.90%
4.18
6.45%
4.50
7.81%
4.48
-0.57%
4.18
-6.61%
4.98
19.02%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.92
1.38%
0.75
20.51%
0.86
16.85%
0.91
29.32%
1.06
15.03%
Revenue
Q2Q % growth
204.43M
9.17%
190.05M
12.51%
200.72M
10.83%
203.7M
13.47%
214.07M
4.72%
EBITDA
Q2Q % growth
58.265M
-45.67%
50.077M
56.39%
55.051M
-6.82%
59.687M
-28.44%
64.97M
11.51%
EBIT
Q2Q % growth
52.894M
85.92%
38.046M
250.59%
49.674M
369.07%
45.594M
232.12%
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.70
-11.39%
0.660.045.28%
Q2 2025
Q2Q % growth
0.74
-16.85%
0.720.022.13%
Q1 2025
Q2Q % growth
0.62 0.610.011.99%
Q4 2024
Q2Q % growth
0.91
2.25%
0.850.066.81%
Q3 2024
Q2Q % growth
0.79
9.72%
0.720.079.93%
Q2 2024
Q2Q % growth
0.89
14.10%
0.710.1824.81%
Q1 2024
Q2Q % growth
0.62
16.98%
0.64-0.02-2.59%
Q4 2023
Q2Q % growth
0.89
11.25%
0.90-0.01-1.23%
Q3 2023
Q2Q % growth
0.72
12.50%
0.80-0.08-9.96%
Q2 2023
Q2Q % growth
0.78
52.94%
0.770.010.88%
Q1 2023
Q2Q % growth
0.53
-17.19%
0.63-0.10-15.78%
Q4 2022
Q2Q % growth
0.80
-17.53%
0.85-0.05-5.48%
Q3 2022
Q2Q % growth
0.64
-11.11%
0.78-0.14-17.87%
Q2 2022
Q2Q % growth
0.51
-33.77%
0.87-0.36-41.29%
Q1 2022
Q2Q % growth
0.64
20.75%
0.85-0.21-24.60%
Q4 2021
Q2Q % growth
0.97
11.49%
0.920.055.31%
Q3 2021
Q2Q % growth
0.72
5.88%
0.670.058.04%
Q2 2021
Q2Q % growth
0.77
541.67%
0.750.022.59%
Q1 2021
Q2Q % growth
0.53 0.65-0.12-18.19%
Q4 2020
Q2Q % growth
0.87 0.840.033.48%
Q3 2020
Q2Q % growth
0.68 0.640.045.69%
Q2 2020
Q2Q % growth
0.12 0.090.0326.79%
Q1 2020
Q2Q % growth
0.53 0.300.2374.37%
PCRX Yearly EPS VS EstimatesPCRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
179.516M
6.49%
186.2M-6.684M-3.59%
Q2 2025
Q2Q % growth
181.099M
1.73%
186.69M-5.591M-2.99%
Q1 2025
Q2Q % growth
168.923M
1.08%
179.55M-10.627M-5.92%
Q4 2024
Q2Q % growth
187.253M
3.32%
188.05M-797K-0.42%
Q3 2024
Q2Q % growth
168.573M
2.83%
173.07M-4.497M-2.60%
Q2 2024
Q2Q % growth
178.023M
5.05%
175.95M2.073M1.18%
Q1 2024
Q2Q % growth
167.117M
4.23%
168.11M-993K-0.59%
Q4 2023
Q2Q % growth
181.244M
5.37%
185.3M-4.056M-2.19%
Q3 2023
Q2Q % growth
163.926M
-2.13%
175.06M-11.134M-6.36%
Q2 2023
Q2Q % growth
169.467M
0.04%
178.1M-8.633M-4.85%
Q1 2023
Q2Q % growth
160.341M
1.48%
162.02M-1.679M-1.04%
Q4 2022
Q2Q % growth
172M
8.04%
176.97M-4.97M-2.81%
Q3 2022
Q2Q % growth
167.5M
31.17%
172.36M-4.86M-2.82%
Q2 2022
Q2Q % growth
169.4M
24.93%
173.71M-4.31M-2.48%
Q1 2022
Q2Q % growth
158M
32.77%
162.53M-4.53M-2.79%
Q4 2021
Q2Q % growth
159.2M
21.53%
159.54M-340K-0.21%
Q3 2021
Q2Q % growth
127.7M
8.68%
132.98M-5.28M-3.97%
Q2 2021
Q2Q % growth
135.6M
79.60%
134.58M1.02M0.76%
Q1 2021
Q2Q % growth
119M
12.58%
121.66M-2.66M-2.19%
Q4 2020
Q2Q % growth
131M 134.2M-3.2M-2.38%
Q3 2020
Q2Q % growth
117.5M 118.05M-550K-0.47%
Q2 2020
Q2Q % growth
75.5M 73.906M1.594M2.16%
Q1 2020
Q2Q % growth
105.7M 104.22M1.48M1.42%
PCRX Yearly Revenue VS EstimatesPCRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.63% 5.02% -0.31% 3.58%
Revenue-0.12% -2.05% -0.03% -0.99%